Business Context and Reporting Period
This Form 8-K Current Report was filed by Neuralstem, Inc. on May 13, 2016, regarding events occurring on May 12, 2016. The filing details the entry into a Material Definitive Agreement involving a private placement of equity securities.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock and warrants.
- Gross Proceeds: $1,080,000.
- Securities Issued: 2,700,000 shares of Common Stock and warrants to purchase 2,700,000 shares.
- Warrant Terms: Initial exercise price of $0.40 per share; exercisable immediately; expire 5 years from issuance.
- Transaction Costs: $50,000 paid to Roth Capital Partners, LLC as financial advisor.
- Anticipated Net Proceeds: Approximately $1.03 million.
- Closing Date: Anticipated on or about May 24, 2016.
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the company's ongoing operations.
Material Changes and Terms
The primary material change is the dilution of existing shareholders through the issuance of 2,700,000 new shares and associated warrants. Key terms include:
- Beneficial Ownership Limitation: Warrants cannot be exercised if the holder would beneficially own more than 4.99% of outstanding shares (electable to 9.99% with notice).
- Anti-Dilution Adjustment: Exercise price adjusts for sales of stock below the exercise price and certain corporate events.
- Extraordinary Transaction: In events like mergers or asset sales, holders may elect cash payment based on the Black-Scholes model value of the warrant.
- Cashless Exercise: If registration is not effective after six months, warrants may be exercised on a cashless basis.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the anticipated closing date and net proceeds. Management notes the following risks and contingencies:
- Closing Conditions: The transaction is subject to customary closing conditions; there is no guarantee the offering will close on time or at all.
- Registration Status: Securities were sold under Section 4(a)(2) exemption and are not registered under the Securities Act of 1933.
- Liquidity of Warrants: Warrants will not be listed on any national securities exchange, and no trading market is expected to develop.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds received by the company.
- Confirm the effective date of the registration statement for shares underlying the warrants to determine if cashless exercise provisions are triggered.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.01) and Warrant (Exhibit 4.01) for specific adjustment formulas and exceptions.
- Monitor subsequent filings for any sales of common stock at prices below the $0.40 warrant exercise price, which would trigger price adjustments.